More on EOLS

- Summary
- Chart
- Profile
- Historical

Data

- Earnings (+100.0% Growth)
- Ratings (7.7 Score)

Upcoming Events

- Earnings (8/5/26 *Est.)

News

- Analyst Ratings
- Earnings Related
- Guidance
- Insider Trades
- Mgmt Changes
- M & A
- Retail Sales
- Rumors
- Stock Buybacks
More...

Evolus (NQ:EOLS)
Delayed: 5.53 -0.13 (2.3%)
Prev. Close $5.66  
Open$5.68 
52 Wk High$ 
52 Wk Low$ 
Day High$5.68 
Day Low$5.17 
P/E N/A  
EPS$ 
Volume1,726,539 


Mar 3, 2026 05:09 PM Form S-8 Evolus, Inc.
Mar 3, 2026 05:03 PM Form 10-K Evolus, Inc. For: Dec 31
Mar 3, 2026 04:30 PM Form 8-K Evolus, Inc. For: Mar 03
Mar 3, 2026 04:10 PM Evolus (EOLS) Misses Q4 EPS by 4c, provides guidance
Mar 3, 2026 04:05 PM Evolus Reports Fourth Quarter and Full-Year 2025 Financial Results; Delivers Sixth Consecutive Year of Double-Digit Growth and Expects Sustainable Profitability¹ Beginning in 2026
Feb 25, 2026 08:00 AM Evolus to Participate in The Leerink Partners Global Healthcare Conference
Feb 19, 2026 08:58 PM Form 4 Evolus, Inc. For: Feb 17 Filed by: Stewart Brady
Feb 19, 2026 08:58 PM Form 4 Evolus, Inc. For: Feb 17 Filed by: Parschauer Karah Herdman
Feb 19, 2026 08:58 PM Form 4 Evolus, Inc. For: Feb 17 Filed by: Mitchell Tatjana
Feb 19, 2026 08:58 PM Form 4 Evolus, Inc. For: Feb 17 Filed by: White Albert G III
View All Articles

Entities mentioned with EOLS

View All Entities